Editöre Mektup
BibTex RIS Kaynak Göster
Yıl 2020, Cilt: 2 Sayı: 2, 49 - 50, 30.08.2020

Öz

Kaynakça

  • 1) World Health Organization. Coronavirus disease (COVID-19) pandemic.https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  • 2) Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020; Feb 26 [Epub ahead of print].
  • 3) Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE et al. Assessing viral Shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020 Mar 24. Pii: S0161-6420(20)30311-0.
  • 4) Wu P, Duan F, Luo C, Liu Q, Qu, X, Liang L et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol. 2020 Mar 31. Doi:10.1001/jamaophthalmol.2020.1291. [Epub ahead of print].
  • 5) Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013.
  • 6) Li C, Tang Y, Chen Z, Wang A, Huang X, Chen Y, et al. Aerosol formation during non-contact “air-puff” tonometry and its significance for prevention of COVID-19. Chin J Exp Ophthalmol. 2020;38(0):E010.

Glaucoma and Possible Risks During SARS-CoV-2 Pandemic

Yıl 2020, Cilt: 2 Sayı: 2, 49 - 50, 30.08.2020

Öz

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has led to a rapid change worldwide. In ophthalmological examination, it was stated that the risk of virus transmission is high. For this reason, special protective equipment had to be put into use. In addition, proper sterilization of the instruments used in the examination and reorganization of the waiting room have gained importance. Nevertheless, it is recommended to postpone routine eye examinations except in emergencies. Glaucoma is a disease managed in the light of the findings obtained during routine examinations. Prolonged pandemic process may lead to irreversible optic nerve damage in patient groups that move away from routine examination.

Kaynakça

  • 1) World Health Organization. Coronavirus disease (COVID-19) pandemic.https://www.who.int/emergencies/diseases/novel-coronavirus-2019
  • 2) Xia J, Tong J, Liu M, Shen Y, Guo D. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection. J Med Virol. 2020; Feb 26 [Epub ahead of print].
  • 3) Seah IYJ, Anderson DE, Kang AEZ, Wang L, Rao P, Young BE et al. Assessing viral Shedding and infectivity of tears in coronavirus disease 2019 (COVID-19) patients. Ophthalmology. 2020 Mar 24. Pii: S0161-6420(20)30311-0.
  • 4) Wu P, Duan F, Luo C, Liu Q, Qu, X, Liang L et al. Characteristics of ocular findings of patients with coronavirus disease 2019 (COVID-19) in Hubei province, China. JAMA Ophthalmol. 2020 Mar 31. Doi:10.1001/jamaophthalmol.2020.1291. [Epub ahead of print].
  • 5) Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014 Nov;121(11):2081-90. doi: 10.1016/j.ophtha.2014.05.013.
  • 6) Li C, Tang Y, Chen Z, Wang A, Huang X, Chen Y, et al. Aerosol formation during non-contact “air-puff” tonometry and its significance for prevention of COVID-19. Chin J Exp Ophthalmol. 2020;38(0):E010.
Toplam 6 adet kaynakça vardır.

Ayrıntılar

Birincil Dil İngilizce
Konular Göz Hastalıkları
Bölüm Letter to The Editor
Yazarlar

Mehmet Murat Uzel

Yayımlanma Tarihi 30 Ağustos 2020
Kabul Tarihi 1 Temmuz 2020
Yayımlandığı Sayı Yıl 2020 Cilt: 2 Sayı: 2

Kaynak Göster

APA Uzel, M. M. (2020). Glaucoma and Possible Risks During SARS-CoV-2 Pandemic. Clinical and Experimental Ocular Trauma and Infection, 2(2), 49-50.
AMA Uzel MM. Glaucoma and Possible Risks During SARS-CoV-2 Pandemic. CEOTI. Ağustos 2020;2(2):49-50.
Chicago Uzel, Mehmet Murat. “Glaucoma and Possible Risks During SARS-CoV-2 Pandemic”. Clinical and Experimental Ocular Trauma and Infection 2, sy. 2 (Ağustos 2020): 49-50.
EndNote Uzel MM (01 Ağustos 2020) Glaucoma and Possible Risks During SARS-CoV-2 Pandemic. Clinical and Experimental Ocular Trauma and Infection 2 2 49–50.
IEEE M. M. Uzel, “Glaucoma and Possible Risks During SARS-CoV-2 Pandemic”, CEOTI, c. 2, sy. 2, ss. 49–50, 2020.
ISNAD Uzel, Mehmet Murat. “Glaucoma and Possible Risks During SARS-CoV-2 Pandemic”. Clinical and Experimental Ocular Trauma and Infection 2/2 (Ağustos 2020), 49-50.
JAMA Uzel MM. Glaucoma and Possible Risks During SARS-CoV-2 Pandemic. CEOTI. 2020;2:49–50.
MLA Uzel, Mehmet Murat. “Glaucoma and Possible Risks During SARS-CoV-2 Pandemic”. Clinical and Experimental Ocular Trauma and Infection, c. 2, sy. 2, 2020, ss. 49-50.
Vancouver Uzel MM. Glaucoma and Possible Risks During SARS-CoV-2 Pandemic. CEOTI. 2020;2(2):49-50.